Large scale expression and purification of recombinant HIV-1 proteinase from Escherichia coli.
The availability of target proteins in sufficient quantity is a limiting factor in crystallographic studies and therefore in rational drug design. Even after optimisation, expression of recombinant proteins may be low and the only way to produce enough protein is by large scale cell growth/purification. HIV-1 proteinase in Escherichia coli, which due to its toxicity is expressed as a soluble protein only at around 0.1% of total protein, is a paradigm for this. In this paper a detailed process for large scale expression and purification of HIV-1 proteinase which delivers material of suitable quantity (30 mg from 500 g of wet weight of cells) and quality for crystallographic studies is described.
Department of Genetics, Glaxo Group Research Ltd., Greenford, Middlesex, U.K.
O M
OM
Singh
D S
DS
Baines
R M
RM
Hall
N M
NM
Gray
M P
MP
Weir
D004926:Escherichia coli / Q000235:genetics* / Q000378:metabolism; D016333:HIV Protease / Q000096:biosynthesis* / Q000302:isolation & purification; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000302:isolation & purification
D011994:Recombinant Proteins; D016333:HIV Protease